Literature DB >> 14563387

Decreased platelet peripheral-type benzodiazepine receptors in persistently violent schizophrenia patients.

Michael Ritsner1, Ilan Modai, Anatoly Gibel, Svetlana Leschiner, Henry Silver, German Tsinovoy, Abraham Weizman, Moshe Gavish.   

Abstract

Peripheral-type benzodiazepine receptors (PBR) have been shown to be sensitive to stressful conditions. This study aimed to explore a possible association of platelets PBR binding with aggressive behavior and homicidal history in schizophrenia patients. The authors compared [(3)H] PK 11195 binding to platelet membrane among 11 currently aggressive schizophrenia patients, 15 schizophrenia patients with homicidal history, 14 nonaggressive schizophrenia patients, and 15 healthy volunteers. Subjects were assessed for aggressive behavior, psychopathology, anxiety, anger, and emotional distress using standardized instruments. We found that currently aggressive patients had significantly lower (-30%) platelet PBR density (B(max)), and scored significantly higher on hostility, anxiety, state anger, and emotional distress compared to homicidal and nonaggressive schizophrenia patients and healthy controls. Predominance of positive or negative symptoms, homicidal or suicidal attempt history, emotional distress levels, and conventional or atypical antipsychotic therapy is not associated with the expression of platelet PBR binding sites. Significant negative correlations emerged between PBR density and scores for aggressive behavior, hostility and anxiety. Thus, decreased platelet PBR density in aggressive schizophrenia patients is associated with higher scores for overt aggression, hostility and anxiety, but independent of illness subtype, homicidal and suicidal attempt history, distress level and type of antipsychotic treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563387     DOI: 10.1016/s0022-3956(03)00055-4

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  12 in total

Review 1.  Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics.

Authors:  Chi-Yu Lai; Elizabeth Scarr; Madhara Udawela; Ian Everall; Wei J Chen; Brian Dean
Journal:  World J Psychiatry       Date:  2016-03-22

2.  Generalization of endothelial modelling of TSPO PET imaging: Considerations on tracer affinities.

Authors:  Gaia Rizzo; Mattia Veronese; Matteo Tonietto; Benedetta Bodini; Bruno Stankoff; Catriona Wimberley; Sonia Lavisse; Michel Bottlaender; Peter S Bloomfield; Oliver Howes; Paolo Zanotti-Fregonara; Federico E Turkheimer; Alessandra Bertoldo
Journal:  J Cereb Blood Flow Metab       Date:  2017-11-14       Impact factor: 6.200

Review 3.  Neurobiology of aggression and violence in schizophrenia.

Authors:  Michael Soyka
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

Review 4.  Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders.

Authors:  Rainer Rupprecht; Vassilios Papadopoulos; Gerhard Rammes; Thomas C Baghai; Jinjiang Fan; Nagaraju Akula; Ghislaine Groyer; David Adams; Michael Schumacher
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

5.  Kinetic modelling of [11C]PBR28 for 18 kDa translocator protein PET data: A validation study of vascular modelling in the brain using XBD173 and tissue analysis.

Authors:  Mattia Veronese; Tiago Reis Marques; Peter S Bloomfield; Gaia Rizzo; Nisha Singh; Deborah Jones; Erjon Agushi; Dominic Mosses; Alessandra Bertoldo; Oliver Howes; Federico Roncaroli; Federico E Turkheimer
Journal:  J Cereb Blood Flow Metab       Date:  2017-06-05       Impact factor: 6.200

6.  A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation.

Authors:  William C Kreisl; Kimberly J Jenko; Christina S Hines; Chul Hyoung Lyoo; Winston Corona; Cheryl L Morse; Sami S Zoghbi; Thomas Hyde; Joel E Kleinman; Victor W Pike; Francis J McMahon; Robert B Innis
Journal:  J Cereb Blood Flow Metab       Date:  2012-09-12       Impact factor: 6.200

7.  External validity of studies on aggressive behavior in patients with schizophrenia: systematic review.

Authors:  Tilman Steinert; Karen Hamann
Journal:  Clin Pract Epidemiol Ment Health       Date:  2012-08-23

Review 8.  Theranostic Biomarkers for Schizophrenia.

Authors:  Matea Nikolac Perkovic; Gordana Nedic Erjavec; Dubravka Svob Strac; Suzana Uzun; Oliver Kozumplik; Nela Pivac
Journal:  Int J Mol Sci       Date:  2017-03-30       Impact factor: 5.923

9.  Genetic analysis of dTSPO, an outer mitochondrial membrane protein, reveals its functions in apoptosis, longevity, and Ab42-induced neurodegeneration.

Authors:  Ran Lin; Alessia Angelin; Federico Da Settimo; Claudia Martini; Sabrina Taliani; Shigong Zhu; Douglas C Wallace
Journal:  Aging Cell       Date:  2014-06       Impact factor: 9.304

Review 10.  The methodology of TSPO imaging with positron emission tomography.

Authors:  Federico E Turkheimer; Gaia Rizzo; Peter S Bloomfield; Oliver Howes; Paolo Zanotti-Fregonara; Alessandra Bertoldo; Mattia Veronese
Journal:  Biochem Soc Trans       Date:  2015-08-03       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.